Information about ExpressMedsCanada.com
List of countries where we can ship Factive:
Latest news releases on Factive:
The decrease was primarily due to the Company's divestiture of its Factive and Spectracef product rights and respiratory sales force. Research and development expenses increased $486,000, or 87%, during the first quarter of 2012 compared to the ...
In subsequent quarters, the revenues from the recently acquired Factive product, which was acquired late in the second quarter, will augment the Company's revenue base. The Company completed its amalgamation on December 19, 2011 and consequently ...